Position in CPRX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$5,677,468
+$325,606 QoQ
Shares Held
229,300
0.0% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swiss National Bank holds $1,640,558,253 across 148 Biotechnology names. CPRX ranks #46 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,600 | $332,493,684 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
303,140 | $234,218,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
387,720 | $128,284,916 | |
| 4 | INSM |
INSMED Inc
|
625,912 | $102,349,130 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,191,100 | $57,137,067 | |
| 6 | INCY |
Incyte Corp
|
489,774 | $46,097,528 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
425,431 | $41,373,164 | |
| 8 | MRNA |
Moderna, Inc.
|
696,100 | $35,361,880 |
All Filings in CPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,677,468 | 229,300 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $5,351,862 | 229,300 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,426,590 | 224,700 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,802,210 | 221,300 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,041,575 | 207,900 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,384,787 | 210,100 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,127,088 | 207,600 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,234,312 | 208,800 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,328,272 | 208,800 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,178,771 | 189,100 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,601,025 | 222,500 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,936,640 | 218,500 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,538,172 | 213,400 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $4,387,740 | 235,900 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,972,711 | 231,700 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,624,217 | 231,700 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,920,793 | 231,700 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,471,798 | 217,400 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,152,220 | 217,400 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,250,050 | 217,400 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,037,250 | 225,000 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $732,462 | 219,300 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $651,321 | 219,300 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,013,166 | 219,300 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $692,615 | 179,900 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||